These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33161498)

  • 1. Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients.
    Akbaba TH; Ustabas G; Kasap-Cuceloglu M; Ozen S; Balci-Peynircioglu B
    Mol Biol Rep; 2020 Nov; 47(11):9005-9011. PubMed ID: 33161498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Mediterranean fever in childhood: a single-center experience.
    Barut K; Sahin S; Adrovic A; Sinoplu AB; Yucel G; Pamuk G; Aydın AK; Dasdemir S; Turanlı ET; Buyru N; Kasapcopur O
    Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
    Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
    J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients.
    Ozen F; Silan C; Uludag A; Candan F; Silan F; Ozdemir S; Atik S; Ozdemir O
    Ren Fail; 2011; 33(9):899-903. PubMed ID: 21851199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canakinumab treatment in four children with colchicine resistant familial mediterranean fever.
    Ozkan S; Atas B
    J Pak Med Assoc; 2017 Jun; 67(6):945-947. PubMed ID: 28585601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
    Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.
    Hashkes PJ; Spalding SJ; Giannini EH; Huang B; Johnson A; Park G; Barron KS; Weisman MH; Pashinian N; Reiff AO; Samuels J; Wright DA; Kastner DL; Lovell DJ
    Ann Intern Med; 2012 Oct; 157(8):533-41. PubMed ID: 23070486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?
    Erden A; Batu ED; Sarı A; Sönmez HE; Armagan B; Demir S; Fırat E; Bilginer Y; Bilgen SA; Karadağ Ö; Kalyoncu U; Kiraz S; Ertenli I; Özen S; Akdogan A
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):97-102. PubMed ID: 30418112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry.
    Batu ED; Şener S; Arslanoglu Aydin E; Aliyev E; Bagrul İ; Türkmen Ş; Akgün Ö; Balık Z; Tanatar A; Bayındır Y; Kızıldağ Z; Torun R; Günalp A; Coşkuner T; İşgüder R; Aydın T; Haşlak F; Kasap Cüceoğlu M; Esen E; Akçay U; Başaran Ö; Pac Kısaarslan A; Akal F; Yüce D; Özdel S; Bülbül M; Bilginer Y; Aktay Ayaz N; Sözeri B; Kasapçopur Ö; Ünsal E; Özen S
    Rheumatology (Oxford); 2024 Mar; 63(3):791-797. PubMed ID: 37228026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age dependent safety and efficacy of colchicine treatment for familial mediterranean fever in children.
    Goldberg O; Levinsky Y; Peled O; Koren G; Harel L; Amarilyo G
    Semin Arthritis Rheum; 2019 Dec; 49(3):459-463. PubMed ID: 31255241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.
    Sönmez HE; Batu ED; Bilginer Y; Özen S
    Clin Rheumatol; 2017 Feb; 36(2):421-425. PubMed ID: 27679472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey.
    Sahin N; Ozdemir Cicek S; Pac Kisaarslan A; Poyrazoglu MH; Gunduz Z; Dusunsel R
    Mod Rheumatol; 2022 Jan; 32(1):177-185. PubMed ID: 33775204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
    Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations.
    Sugiura T; Kawaguchi Y; Fujikawa S; Hirano Y; Igarashi T; Kawamoto M; Takagi K; Hara M; Kamatani N
    Mod Rheumatol; 2008; 18(1):57-9. PubMed ID: 18097735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. About colchicine compliance, resistance and virulence.
    Ben-Chetrit E; Aamar S
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S1-3. PubMed ID: 19796522
    [No Abstract]   [Full Text] [Related]  

  • 18. Do all colchicine preparations have the same effectiveness in patients with familial Mediterranean fever?
    Baglan E; Ozdel S; Bulbul M
    Mod Rheumatol; 2021 Mar; 31(2):481-484. PubMed ID: 32613873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
    Sozeri B; Kasapcopur O
    Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment.
    Sgouropoulou V; Stabouli S; Trachana M
    Clin Rheumatol; 2019 Sep; 38(9):2577-2584. PubMed ID: 31127463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.